Mirum Pharmaceuticals (MIRM) Leases (2019 - 2026)

Mirum Pharmaceuticals has reported Leases for 8 years, with the latest figure at $12.6 million in Q1 2026.

• For the quarter ending Q1 2026, Leases rose 65.04% year-over-year to $12.6 million; the trailing twelve-month figure through Mar 2026 stood at $12.6 million (up 65.04% YoY), and the FY2025 full-year result was $8.7 million, up 0.76% from the prior year.
• Leases for Q1 2026 stood at $12.6 million, up from $8.7 million in the prior quarter.
• The five-year high for Leases was $12.6 million in Q1 2026, with the low at $300000.0 in Q2 2022.
• Average Leases over 5 years is $4.9 million, with a median of $1.6 million recorded in 2023.
• Year-over-year, Leases tumbled 83.33% in 2022 and jumped 1026.91% in 2025.
• Tracing MIRM's Leases over 5 years: stood at $1.4 million in 2022, then dropped by 10.27% to $1.3 million in 2023, then surged by 575.62% to $8.7 million in 2024, then gained by 0.76% to $8.7 million in 2025, then surged by 44.69% to $12.6 million in 2026.
• The last three Leases figures came in at $12.6 million (Q1 2026), $8.7 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.

Peer Comparison